Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00623090 · ClinicalTrials.gov registry record · Phase 3
Internet-Based Education for Prostate Cancer Screening
A Phase 3 study, sponsored by Georgetown University.
- Completed
- Registry status
- Phase 3
- Development phase
- 1,893
- Enrollment target
NCT00623090 is a Phase 3 study that has completed, run by Georgetown University. The registered enrollment target is 1,893 participants.
The verdict
NCT00623090, a Phase 3 study, has completed, sponsored by Georgetown University.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1,893 participants
- Enrollment target
Study Summary
Prostate cancer (PCa) is the leading cancer diagnosis among men and the second leading cause of male cancer death. However, screening asymptomatic men remains controversial, as early diagnosis and treatment of PCa has not yet demonstrated reduced disease-related mortality in a randomized trial. The goal of the current study is to develop and assess widely accessible methods to assist men in making informed decisions about PCa screening. We will compare the efficacy of a new web-based, interactive decision support approach to our existing print-based PCa screening decision tool, among a diverse sample of male primary care patients. Abundant evidence documents the expanding role of the Internet in increasing access to and understanding of health information and the need for systematic evaluations of Internet-based interventions. A novel aspect of the proposed trial will be our focus on cognitive biases as a factor that has limited the success of previous information-based interventions. Specifically, we will evaluate: 1) confirmation bias and 2) short-term consequences bias.
Interventions
- BEHAVIORAL Usual care
- BEHAVIORAL educational internet site on prostate cancer screening
- BEHAVIORAL Educational print booklet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,893 participants |
| Start Date | 2007-10 |
| Est. Completion | 2011-08 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00623090
The ClinicalTrials.gov registry entry for NCT00623090 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 1,893 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Georgetown University, which has 227 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Usual care is the first listed.
NCT00623090 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00623090 about?
NCT00623090 is a clinical study titled "Internet-Based Education for Prostate Cancer Screening". Prostate cancer (PCa) is the leading cancer diagnosis among men and the second leading cause of male cancer death. However, screening asymptomatic men remains controversial, as early diagnosis and treatment of PCa has not yet demonstrated reduced disease-related mortality in a randomized trial. The ...
What is the current status of trial NCT00623090?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 1,893 participants. The study started on 2007-10. Estimated completion is 2011-08.
What interventions are being tested in trial NCT00623090?
The interventions under investigation include: Usual care (BEHAVIORAL), educational internet site on prostate cancer screening (BEHAVIORAL), Educational print booklet (BEHAVIORAL).
Who is sponsoring clinical trial NCT00623090?
This trial is sponsored by Georgetown University, which has 227 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.